Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different MechanismsJin-Ho Kang(Korea University), Kyong Hwa Park(Korea University)Cancer Research and TreatmentSeptember 21, 201510.4143/crt.2015.227Cited by 30SaveCiteExport RISWatch citationsRelated PapersAbemaciclib plus fulvestrant vs fulvestrant alone for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy: Primary outcome of the phase 3 postMONARCH trial.|Journal of Clinical Oncology|2024|75A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment|Scientific Reports|2019|27